Showing results (41-50 of 46) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 46 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 12, 2014
CD49d is the strongest flow cytometry-based predictor of overall survival in chronic lymphocytic leukemiaPietro Bulian, Tait D Shanafelt, Chris Fegan, et al.
International Journal of Cancer|January 6, 2011
Regulatory BCL2 promoter polymorphism (-938C>A) is associated with adverse outcome in patients with prostate carcinomaHagen S Bachmann, Lukas C Heukamp, Klaus J Schmitz, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|June 5, 2013
Treatment with Thalidomide and Cyclophosphamide (TCID) is Superior to Vincristine (VID) and to Vinorelbine (VRID) Regimens in Patients with Refractory or Recurrent Multiple MyelomaBritta Auel, Hartmut Goldschmidt, Thomas Geer, et al.
Haematologica|August 2, 2014
MDM2 promotor polymorphism and disease characteristics in chronic lymphocytic leukemia: results of an individual patient data-based meta-analysisAxel Benner, Larry Mansouri, Davide Rossi, et al.
Blood|January 16, 2010
A variant allele of Growth Factor Independence 1 (GFI1) is associated with acute myeloid leukemiaCyrus Khandanpour, Christian Thiede, Peter J M Valk, et al.
Annals of Hematology|January 6, 2019
Six versus eight doses of rituximab in patients with aggressive B cell lymphoma receiving six cycles of CHOP: results from the "Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphomas" (PETAL) trialAndreas Hüttmann, Jan Rekowski, Stefan P Müller, et al.
Pageof 5